Connect with us

Tampa company raises $6 million to develop potential Covid-19 vaccine

November 25, 2020 - Oragenics, a Tampa company focused on creating a vaccine candidate to combat the novel coronavirus pandemic, has raised about $6 million in a public stock offering. Oragenics (NYSE American: OGEN) sold nearly 14.2 million shares at 37 cents a share. In addition, the underwriter on the offering  exercised its option to purchase an additional 2.1 million shares of common stock. a news release said. Oragenics intends to use the proceeds of the offering primarily to continue funding pre-clinical development of its SARS-CoV-2 vaccine, Terra CoV-2, and its lantibiotics program and for general corporate purposes, including research and development activities, capital expenditures and working capital, according to the news release. 

More Zaps Frontpage

The St. Pete Catalyst

The Catalyst honors its name by aggregating & curating the sparks that propel the St Pete engine.  It is a modern news platform, powered by community sourced content and augmented with directed coverage.  Bring your news, your perspective and your spark to the St Pete Catalyst and take your seat at the table.

Email us: spark@stpetecatalyst.com

Subscribe for Free

Share with friend

Enter the details of the person you want to share this article with.